NuVasive Announces Vertera Spine Buyout, Boosts Implants Suite
Zacks Investment Research | Sep 07, 2017 10:00PM ET
In a bid to expand its advanced materials science range, NuVasive, Inc. (NASDAQ:NUVA) recently announced the Vertera Spine buyout. However, the terms of the acquisition agreement have been kept under wraps.
NuVasive, a pioneer in applying procedurally-integrated solutions for minimally disruptive spine surgeries, aims to market and distribute Vetera Spine’s FDA-approved COHERE Cervical and COALESCETM Lumbar Interbody fusion devices in the United States. This deal will also lend the company a three-dimensional porous interbody technology across both polyetheretherketone (PEEK) and titanium materials. Notably, the company has introduced a few new features in its Modulus XLIF built on a fully-porous titanium implant created in a three-dimensional manufacturing process and designed to match the porosity and stiffness of bone.
We encouragingly note that the company’s U.S. Spinal Hardware business, comprising implants and fixation products, MAGEC-EOS spinal bracing and lengthening system and the PRECICE limb lengthening system, registered 3% growth in the last reported quarter. NuVasive is leaving no stone unturned to gain traction in the fast growing spine market. In this regard, the company has been steadily focusing on product development. Moreover, the company claims to have an active corporate development pipeline that includes a number of strategic investments, acquisitions and partnership opportunities. Notably, during the first quarter of 2017, the company launched the first two interbody devices, MLX and TLX, used in lumbar fusion procedures.
Per a report from BECKER’s SPINE REVIEW, the global minimally-invasive spine surgery market is expected to witness a CAGR of 7.6% between 2017 and 2021. Also, per a report by Technavio, the global spinal implants market is expected to witness a CAGR of roughly 6% in the 2016-2020 period.
Thus, given the current market potential, we believe that the company is on the right track to gain traction.
We believe an ageing population, unhealthy lifestyle and rising awareness and expenditure in healthcare will continue to drive growth in the minimally-invasive spine surgery market. However, this market is dominated by many well-established players like Stryker Corporation (NYSE:SYK) and Zimmer Biomet Holdings, Inc. (NYSE:ZBH) . Notably, Stryker provides a range of products with ES2 Spinal systems, MANTIS implants, LITe Decompression tubes and many more under its minimally invasive spine surgical solutions portfolio. Moreover, Zimmer Biomet’s range of thoracolumbar products forms a comprehensive portfolio for minimally-invasive spine surgery.
Over the past three months, NuVasive has underperformed the broader Original post
Get The News You Want
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.